Rosen Law Firm & Disc Medicine
3 shared events · Importance 3 · Last updated May 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Rosen Law Firm: Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. on behalf of its shareholders, seeking to recover investor losses.
Disc Medicine: Disc Medicine received a Complete Response Letter from the United States — Food and Drug Administration for its bitopertin program, leading to a significant drop in its stock price and a securities investigation.
Apr 29, 2026 · 20 articles
Regulatory
Disc Medicine: Disc Medicine, Inc. received a Complete Response Letter from the United States — Food and Drug Administration regarding its bitopertin program, leading to a 22% stock price drop and subsequent securities claims investigation.
May 01, 2026 · 6 articles
75
Rosen Law Firm investigates securities claims Disc MedicineRosen Law Firm...
NEWSDESK
Explore this relationship live
Track how Rosen Law Firm and Disc Medicine interact across events, view sentiment trends, and discover connected entities.
Open Dashboard